Veracyte is a global diagnostics company that offers genomic sequencing classifiers for cancer diagnosis, including breast, prostate, lung, and colon cancer. The company is also developing new tests and technologies to inform treatment decisions and has licensing and collaboration agreements with Johnson & Johnson, Acerta Pharma, and CareDx. Veracyte was founded in 2006 and is headquartered in South San Francisco, California.